Browsing: Alzheimer’s

Eli Lilly’s Alzheimer’s drug approved in Japan

By 0

Eli Lilly gains approval for their Alzheimer’s drug donanemab (Kisunla) in Japan, offering another treatment targeting amyloid plaques like Eisai’s Leqembi as the ageing population drives a rise in dementia cases.

Metro Manila opens Memory Care Centers (MCC) in its Top Three Hospitals

By 0

Discover comprehensive Memory Care Centers (MCCs) at Metro Manila’s top hospitals – Makati Medical Center, Cardinal Santos Medical Center, and De Los Santos Medical Center. These specialized facilities offer personalized services for Alzheimer’s and dementia patients, including neurological testing, innovative treatments, and supportive care management. Learn about the prevalence of dementia in the Philippines and the essential services provided by these MCCs to enhance the quality of life for affected individuals. Join the movement towards improved mental wellness and healthcare accessibility in the country.

“Never too early, never too late” – Identify Alzheimer’s Risk And Be Proactive

By 0

World Alzheimer’s Day, celebrated globally every 21st September, serves as a watershed moment for raising awareness and combating the stigma of Alzheimer’s disease. Particularly in Asia, where a staggering 23 million individuals are estimated to be living with dementia, this day has played a crucial role in sparking conversations and urging interventions.

Rising Expectations for Alzheimer’s Disease Treatment in Japan

By 1

A novel Alzheimer’s disease treatment drug, lecanemab, developed by Japanese pharmaceutical company Eisai and US firm Biogen, is nearing full approval in the US. Excitement is also building in Japan where the population of Alzheimer’s patients is growing and Prime Minister Fumio Kishida has prioritised dementia. The drug is undergoing an expedited review by the Japanese Pharmaceuticals and Medical Devices Agency and could potentially be approved this autumn.